Literature DB >> 29414303

Long noncoding RNAs in cancer cells.

Duc-Hiep Bach1, Sang Kook Lee2.   

Abstract

Long noncoding RNA (lncRNA) has recently been investigated as key modulators that regulate many biological processes in human cancers via diverse mechanisms. LncRNAs can interact with macromolecules such as DNA, RNA, or protein to exert cellular effects and to act as either tumor promoters or tumor suppressors in various malignancies. Moreover, the aberrant expression of lncRNAs may be detected in multiple cancer phenotypes by employing the rapidly developing modern gene chip technology and bioinformatics analysis. Herein, we highlight the mechanisms of action of lncRNAs, their functional cellular roles and their involvement in cancer progression. Finally, we provide an overview of recent progress in the lncRNA field and future potential for lncRNAs as cancer diagnostic markers and therapeutics.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cancer biomarker; Drug-resistance; Hallmarks of cancer; Oncogene; lncRNAs

Mesh:

Substances:

Year:  2018        PMID: 29414303     DOI: 10.1016/j.canlet.2018.01.053

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  55 in total

1.  Overexpression of long non-coding RNA WT1-AS or silencing of PIK3AP1 are inhibitory to cervical cancer progression.

Authors:  Wenjuan Tong; Huiming Zhang
Journal:  Cell Cycle       Date:  2021-11-28       Impact factor: 4.534

2.  Long non-coding RNA LINC00858 aggravates the oncogenic phenotypes of ovarian cancer cells through miR-134-5p/RAD18 signaling.

Authors:  Heng Xue; Zhihui Wu; Dongdong Rao; Bimin Zhuo; Qingquan Chen
Journal:  Arch Gynecol Obstet       Date:  2020-09-01       Impact factor: 2.344

3.  Targeting Nicotinamide N-Methyltransferase and miR-449a in EGFR-TKI-Resistant Non-Small-Cell Lung Cancer Cells.

Authors:  Duc-Hiep Bach; Donghwa Kim; Song Yi Bae; Won Kyung Kim; Ji-Young Hong; Hye-Jung Lee; Nirmal Rajasekaran; Soonbum Kwon; Yanhua Fan; Thi-Thu-Trang Luu; Young Kee Shin; Jeeyeon Lee; Sang Kook Lee
Journal:  Mol Ther Nucleic Acids       Date:  2018-03-29       Impact factor: 8.886

4.  Microarray analysis of the expression profile of immune-related gene in rapid recurrence early-stage lung adenocarcinoma.

Authors:  Jie Liu; Xiao Yang; Liang Zhang; Bo Yang; Wen Rao; Mengxia Li; Nan Dai; Yuxin Yang; Chengyuan Qian; Lei Zhang; Hualiang Xiao; Dong Wang
Journal:  J Cancer Res Clin Oncol       Date:  2020-06-18       Impact factor: 4.553

5.  Microarray analysis of formalin-fixed, paraffin-embedded follicular thyroid carcinoma samples from patients who developed postoperative distant metastasis.

Authors:  Tomoo Jikuzono; Tomoko Ishikawa; Mitsuyoshi Hirokawa; Iwao Sugitani; Osamu Ishibashi
Journal:  BMC Res Notes       Date:  2020-05-13

6.  LncRNA PTAR promotes EMT and invasion-metastasis in serous ovarian cancer by competitively binding miR-101-3p to regulate ZEB1 expression.

Authors:  Haihai Liang; Tong Yu; Yue Han; Hua Jiang; Chengyu Wang; Tianyi You; Xiaoguang Zhao; Huitong Shan; Rui Yang; Lida Yang; Hongli Shan; Yunyan Gu
Journal:  Mol Cancer       Date:  2018-08-11       Impact factor: 27.401

7.  Long Noncoding RNA WDFY3-AS2 Represses the Progression of Esophageal Cancer through miR-18a/PTEN Axis.

Authors:  Qingling Kong; Guangcai Li; Gang Yin; Kun Li; Dongqing Zhang; Weihao Xu
Journal:  J Oncol       Date:  2021-06-05       Impact factor: 4.375

8.  Hub Long Noncoding RNAs with m6A Modification for Signatures and Prognostic Values in Kidney Renal Clear Cell Carcinoma.

Authors:  Gaoteng Lin; Huadong Wang; Yuqi Wu; Keruo Wang; Gang Li
Journal:  Front Mol Biosci       Date:  2021-07-06

Review 9.  Long noncoding RNAs in gastric cancer: From molecular dissection to clinical application.

Authors:  Yue Gao; Jun-Wei Wang; Jia-Yi Ren; Mian Guo; Cheng-Wang Guo; Shang-Wei Ning; Shan Yu
Journal:  World J Gastroenterol       Date:  2020-06-28       Impact factor: 5.742

10.  lncRNA MALAT1/miR‑26a/26b/ST8SIA4 axis mediates cell invasion and migration in breast cancer cell lines.

Authors:  Nan Wang; Shengji Cao; Xiaoxi Wang; Lina Zhang; Hong Yuan; Xiaolu Ma
Journal:  Oncol Rep       Date:  2021-07-19       Impact factor: 3.906

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.